Journals / Retina-Vitreus / 2021 / Cilt: 30 - Sayı: 1

Ocular Findings of a Patient with Fabry Disease

Pages
96–98
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Ocular fi ndings are an early onset of the disease, so clinical examination of these fi ndings are important to suspect and request consultations from other clinical disciplines to establish a defi nitive diagnosis earlier.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this report is to describe the ophthalmic fi ndings of a 27-year-old patient with Fabry disease.
📊
Key Findings & Data:Best corrected visual acuity was 20/20 and intraocular pressure was 19 mmHg in both eyes.
💡
Conclusion & Impact:Ocular fi ndings are an early onset of the disease, so clinical examination of these fi ndings are important to suspect and request consultations from other clinical disciplines to establish a defi nitive diagnosis earlier.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this report is to describe the ophthalmic fi ndings of a 27-year-old patient with Fabry disease. Best corrected visual acuity was 20/20 and intraocular pressure was 19 mmHg in both eyes. There was an infi ltrate on cornea bilaterally (cornea verticillata), increased tortuosity in conjunctival vessels, a hemangioma on the lower lid of the right eye. The temporal paleness of both optic nerves was noticed with slit lamp biomicroscope and colored fundus photography. Also, there was mild venous tortuosity in retinal vessels. Visual fi eld test, tear function tests, SdOCT fi ndings were all normal in both eyes. In Fabry disease, clinical manifestations begin in childhood, and it affects multiple organ systems which can lead to an early death. Ocular fi ndings are an early onset of the disease, so clinical examination of these fi ndings are important to suspect and request consultations from other clinical disciplines to establish a defi nitive diagnosis earlier.

🔖

Cite This Article

AVARİSLİ, N. A., BİÇER, T. (2022). Ocular Findings of a Patient with Fabry Disease. Retina-Vitreus, Cilt: 30 - Sayı: 1, 96–98. https://ajindex.com/articles/589054

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Meikle PJ, Hopwood JJ, Clague AE, et al. Prevalence of lysosomal storage disorders. JAMA 1999;281:249-54
  2. Samiy N. Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder. Surv Ophthalmol 2008;53:416-23
  3. Hopkin RJ, Bissler J, Banikazemi M, et al. Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry. Pediatr Res 2008;64:550
  4. Mehta A, Ricci R, Widmer U, et al. Fabry disease defi ned: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 2004;34:236-42
  5. Pitz S, Kalkum G, Arash L, et al. Ocular signs correlate well with disease severity and genotype in Fabry disease. PLoS One 2015;10:e0120814
  6. Utsumi K, Ueda K, Watanabe M, et al. Thrombosis in Japanese patients with Fabry disease. J Neurol Sci 2009;283:83-5
  7. Desnick RJ. Fabry disease: α-galactosidase A defi ciency. In: Roger N. Rosenberg, Juan M. Pascual: Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, Elsevier. 2015;419-30
  8. Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease: infl uence of α-galactosidase A activity and genetic mutations on clinical course. Medicine 2002; 81:122-38.